Identification of a Population of Epidermal Squamous Cell Carcinoma Cells with Enhanced Potential for Tumor Formation
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of a Population of Epidermal Squamous Cell Carcinoma Cells with Enhanced Potential for Tumor Formation
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 12, Pages e84324
Publisher
Public Library of Science (PLoS)
Online
2013-12-21
DOI
10.1371/journal.pone.0084324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer stem-like cells enriched with CD29 and CD44 markers exhibit molecular characteristics with epithelial–mesenchymal transition in squamous cell carcinoma
- (2012) Songmei Geng et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Biochemistry of epidermal stem cells
- (2012) Richard L. Eckert et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Cancer-initiating cells derived from established cervical cell lines exhibit stem-cell markers and increased radioresistance
- (2012) Jacqueline López et al. BMC CANCER
- EZH2 inhibition: targeting the crossroad of tumor invasion and angiogenesis
- (2012) Francesco Crea et al. CANCER AND METASTASIS REVIEWS
- A Proteasome Inhibitor-stimulated Nrf1 Protein-dependent Compensatory Increase in Proteasome Subunit Gene Expression Reduces Polycomb Group Protein Level
- (2012) Sivaprakasam Balasubramanian et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
- (2012) Yi-Che Changchien et al. Journal of Translational Medicine
- EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations
- (2012) Michael T. McCabe et al. NATURE
- Keratinocyte Stem Cells and the Targets for Nonmelanoma Skin Cancer†
- (2012) Ashok Singh et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- Loss of Let-7 Up-Regulates EZH2 in Prostate Cancer Consistent with the Acquisition of Cancer Stem Cell Signatures That Are Attenuated by BR-DIM
- (2012) Dejuan Kong et al. PLoS One
- Promotion of Glioblastoma Cell Motility by Enhancer of Zeste Homolog 2 (EZH2) Is Mediated by AXL Receptor Kinase
- (2012) Martina Ott et al. PLoS One
- Isolation and identification of a distinct side population cancer cells in the human epidermal squamous cancer cell line A431
- (2011) Songmei Geng et al. ARCHIVES OF DERMATOLOGICAL RESEARCH
- Cancer Stem Cells in Squamous Cell Carcinoma Switch between Two Distinct Phenotypes That Are Preferentially Migratory or Proliferative
- (2011) A. Biddle et al. CANCER RESEARCH
- (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells
- (2011) S. R. Choudhury et al. CARCINOGENESIS
- A Humanized Stromal Bed Is Required for Engraftment of Isolated Human Primary Squamous Cell Carcinoma Cells in Immunocompromised Mice
- (2011) Girish K. Patel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Identification and Characterization of Tumor-Initiating Cells in Human Primary Cutaneous Squamous Cell Carcinoma
- (2011) Girish K. Patel et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- A vascular niche and a VEGF–Nrp1 loop regulate the initiation and stemness of skin tumours
- (2011) Benjamin Beck et al. NATURE
- The cancer stem cell: premises, promises and challenges
- (2011) Hans Clevers NATURE MEDICINE
- Evidence for Epithelial-Mesenchymal Transition in Cancer Stem Cells of Head and Neck Squamous Cell Carcinoma
- (2011) Chao Chen et al. PLoS One
- Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment
- (2011) Rita Mancini et al. PLoS One
- Tumor initiating cells: Development and critical characterization of a model derived from the A431 carcinoma cell line forming spheres in suspension
- (2010) Ileana Bortolomai et al. CELL CYCLE
- Keratinocyte stem cells: Friends and foes
- (2010) Carlo Pincelli et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Polycomb Group Proteins Are Key Regulators of Keratinocyte Function
- (2010) Richard L. Eckert et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer
- (2009) Yu-Chih Chen et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- EZH2 Is Essential for Glioblastoma Cancer Stem Cell Maintenance
- (2009) M.-L. Suva et al. CANCER RESEARCH
- Aldehyde Dehydrogenase 1 Is a Marker for Normal and Malignant Human Colonic Stem Cells (SC) and Tracks SC Overpopulation during Colon Tumorigenesis
- (2009) E. H. Huang et al. CANCER RESEARCH
- The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival
- (2009) S. Balasubramanian et al. CARCINOGENESIS
- Differential expression of stem-cell-associated markers in human hair follicle epithelial cells
- (2009) Keita Inoue et al. LABORATORY INVESTIGATION
- Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer
- (2009) F. Jiang et al. MOLECULAR CANCER RESEARCH
- Positive Correlations of Oct-4 and Nanog in Oral Cancer Stem-Like Cells and High-Grade Oral Squamous Cell Carcinoma
- (2008) S.-H. Chiou et al. CLINICAL CANCER RESEARCH
- Aldehyde Dehydrogenase Discriminates the CD133 Liver Cancer Stem Cell Populations
- (2008) S. Ma et al. MOLECULAR CANCER RESEARCH
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- An embryonic stem cell–like gene expression signature in poorly differentiated aggressive human tumors
- (2008) Ittai Ben-Porath et al. NATURE GENETICS
- The Bmi-1 polycomb group gene in skin cancer: regulation of function by (−)-epigallocatechin-3-gallate
- (2008) Sivaprakasam Balasubramanian et al. NUTRITION REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started